It is now generally recognized that removal with as wide a margin as possible is the treatment of choice for pleomorphic adenomas. The modern approach of parotidectomy with nerve identification and preservation has evolved over the last thirty years as a result of the efforts of many people, but notably Redon (1935) and Hamilton Bailey (1941) . The operation, which is often referred to as a conservative parotidectomy, entails either the removal of the superfacial part of the gland, or total removal of the gland, the nerve being preserved in each case.
Total conservative parotidectomy for tumours in the superfacial compartment has been justified on the basis of the alleged multifocal origin of mixed tumours. However, if these neoplasms are examined by serial sectioning, consecutive sections will show that nodules lying on the periphery of the main tumour but seemingly separate from it are in fact merely extensions of the tumour. True multiple nodularity can occur, but nearly always as a result of seeding from biopsies, or the incomplete removal of primary tumours (Foote & Frazell 1954 , Patey & Thackray 1958 , Eneroth 1964 . More recently the operation of total conservative parotidectomy has been used only for those tumours arising in the subfacial lobe of the parotid and for recurrent mixed tumours.
It is only recently that clinicians have become aware of the behavioural characteristics of malignant salivary gland tumours. The relatively slow growth of the mucoepidermoid, adenocystic, and acinic cell carcinomas and the late appearance of metastases in these cases put them in a special category, whereas squamous carcinoma and a variety of undifferentiated tumours exhibiting a more aggressive behaviour must be regarded in an altogether different light. Apart from considerations of size, precise location, and facial nerve involvement, the treatment plan for any given tumour should be guided by its histology. Conley (1957) favours the removal of low grade carcinomas by total conservative parotidectomy.
A similar approach is advocated for some of the smaller high-grade tumours which have not obviously invaded the facial nerve, but with the addition of a block dissection. Tumours occupying a large pert of the superfacial parotid or arising in the 'deep parotid are treated by radical parotidectomy. The same applies when the facial nerve is involved by growth, although it may be possible on occasions to salvage part of the nerve, particularly if the neoplasm is of the low grade type.
The patient who loses one branch of the facial nerve may exhibit little or no permanent weakness, since distal re-innervation of the paralysed segment may take place through connexions from adjacent intact branches. The one exception to this is the mandibular branch, which receives peripheral connexions from the cervical branch only. Even sacrifice of one main division may be compatible with a reasonable degree of facial symmetry and the eventual return of some muscle power. Total loss of the facial nerve results in considerable deformity and psychological handicap. Where radical parotidectomy is performed, it would seem reasonable to repair the deficit with a three, four, or five pronged nerve graft taken from the cervical plexus, preferably from the opposite side of the neck. In successful cases, function returns to the face at the end of six or seven months, first as facial symmetry at rest, and later as active voluntary contractions.
With regard to block dissection, there is no unanimity of opinion as to the proper indications for this procedure or its value to the patient. There are some like Conley (1957) who resort to it in the absence of palpable nodes, especially when dealing with the more aggressive type of tumour. Others advocate waiting until the nodes become obviously palpable; but, as McCabe & Boles (1962) have pointed out, survival rates are in no way increased by performing block dissections on patients with obvious lymph node involvement. In view of the uncertainty about this procedure, it would seem reasonable to await developments in cases of low-grade tumours because of the relative infrequency of metastasis; whereas neck dissection could be reserved for those neoplasms which carry an obviously poorer prognosis and those with established node involvement.
It seems remarkable that, in view of the poor results of treatment for carcinoma of the parotid, the principle of treating with radiotherapy first, followed by surgery afterwards, has not been given a fair trial. This is a theme which is familiar to the otolaryngologist in cases of carcinoma of the antrum and larynx, with rather more encouraging results than those obtained by treating with one modality alone. If such a plan were adopted, the radiotherapist would gain by treating the tumour under optimal conditions. The surgeon, on the other hand, would have to reconcile himself to slightly more difficult conditions, and the possible disadvantage of having to await the completion of radiotherapy before excising what may be a contaminated biopsy track. In this respect, it would be interesting to determine how effective radiotherapy could be in the sterilization of cells spilled into the wound at the time of biopsy. One of the possible benefits of the suggested treatment plan may lie in the extent to which sacrifice of the facial nerve may be averted.
There temains a category of tumour in which this plan can never be anticipated. Namely the tumour which is clinically benign, but turns out at operation to be malignant. Clearly this is an instance when radiotherapy must follow surgery.
Dr S Rafla (Manitoba Cancer Treatment and Research Foundation, Winnipeg General Hospital, Winnipeg, Canada)
This paper reviews 407 cases of mucous and salivary gland tumours, treated in the Royal Marsden Hospital, London. The majority of these patients were under the care of Dr M Lederman, and I am grateful to him for permitting me to report on them.
Cases originating in major salivary glands numbered 268 and the rest occurred in ectopic sites mostly in the upper air and food passages.
Pleomorphic adenomas (172 cases) were treated mostly with enucleation and radiotherapy. Spillage of the tumour during enucleation was reported in 14 cases. In a follow-up period of five to fifteen years, only 6 cases recurred (3 5 %). The response of pleomorphic adenoma to radiotherapy was assessed in 60 cases. While 10% of parotid tumours disappeared under radiotherapy, one-third of tumours in ectopic sites did the same. The results of this method of treatment seem to compare favourably with more radical methods, e.g. parotidectomy.
The different malignant forms comprise 179 cases: cylindromas 54, adenocarcinomas 71, and 54 distributed among less common types like malignant mixed tumours and mucoepidermoids. The treatment of malignant tumours was essentially a combination of surgerymostly excisionand radiotherapy. In this context excision means removal of the portion of the gland containing tumour. However, 81 cases were treated with radiotherapy alone either because the case was deemed inoperable or because it disappeared completely under radiotherapy which was used as the primary method of treatment due to unfavourable features, e.g. skin involvement or deep fixation.
Of 99 cases 30 (30%) were alive and well after five years while only 6 out of 37 (160%) survived for ten years. These bad results are unfortunately in agreement with other series even when more radical methods were applied.
Nerve involvement by disease, a finding not reported in any of the 172 pleomorphic adenomas, was noted in 29 of the malignant tumours. This finding is of serious significance; about half the 29 patients continued to have persistent disease after treatment and none remained alive and free of disease for five years.
Lymphatic metastases were noticed in about one-quarter of the patients, whose prognosis depended on the stage of nodal involvement. Where the nodes were deeply fixed or where contralateral ones were affected, none of the patients lived free of disease for five years. About one-fifth of the patients suffered from distant metastases. While such patients may live for a relatively long time, this happens only in patients with pulmonary metastases; the longest survival of a patient with bone metastasis was less than two years.
It was possible to assess the response of 67 tumours to radiotherapy, 23 (35 %) of which disappeared under treatment. Cylindroma and adenocarcinoma are relatively more radiosensitive than other types. Cases in which the tumour disappeared under radiotherapy seem to do relatively well, the five-year survival being 57 %.
Dr J G Stewart (Christie Hospital and Holt Radium Institute, Manchester)
Radiotherapy
The role of radiotherapy in the management of these tumours has never been clearly defined. In the past surgery has been regarded as the treatment of choice, with radiotherapy reserved for recurrent or inoperable cases. Such selection has made the assessment of the role of radiotherapy difficult.
